CTC
TARO

Central Trust Company’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Central Trust Company’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-8
Closed – – 1481
2022
Q1 		$0 Buy
+8
New +$374 ﹤0.01% 1525

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Central Trust Company's TARO Position: Q2 2022 in Review

Central Trust Company sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2022, closing a stake of 8 shares.

Central Trust Company first reported a position in TARO in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 72 funds tracked by Wall St. Rank hold TARO as of Q2 2022.

  • Central Trust Company reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2022 after selling out during the quarter.
  • Central Trust Company sold 8 Taro Pharmaceutical Industries Ltd. shares in Q2 2022.
  • Central Trust Company first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2022 and held it in 1 quarter.
  • Central Trust Company's Taro Pharmaceutical Industries Ltd. position peaked at $0 in Q1 2022.
  • 72 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2022.

Based on Central Trust Company's 13F filing for Q2 2022, filed 9 Aug 2022.